Jocelyn Trottier

2.5k total citations
44 papers, 1.9k citations indexed

About

Jocelyn Trottier is a scholar working on Oncology, Epidemiology and Pharmacology. According to data from OpenAlex, Jocelyn Trottier has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 20 papers in Epidemiology and 15 papers in Pharmacology. Recurrent topics in Jocelyn Trottier's work include Drug Transport and Resistance Mechanisms (21 papers), Liver Disease Diagnosis and Treatment (17 papers) and Pharmacogenetics and Drug Metabolism (14 papers). Jocelyn Trottier is often cited by papers focused on Drug Transport and Resistance Mechanisms (21 papers), Liver Disease Diagnosis and Treatment (17 papers) and Pharmacogenetics and Drug Metabolism (14 papers). Jocelyn Trottier collaborates with scholars based in Canada, Poland and United States. Jocelyn Trottier's co-authors include Olivier Barbier, Patrick Caron, Piotr Milkiewicz, Mélanie Verreault, Jenny Kaeding, Li Wang, André Marette, Andrzej Białek, Robert J. Straka and Li Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Jocelyn Trottier

44 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jocelyn Trottier Canada	22	842	614	552	408	357	44	1.9k
Shogo Takahashi United States	25	1.3k 1.5×	763 1.2×	1.0k 1.9×	535 1.3×	216 0.6×	37	2.5k
Emily C. Gurley United States	28	1.2k 1.4×	722 1.2×	862 1.6×	786 1.9×	330 0.9×	44	2.8k
Alan Medline Canada	22	660 0.8×	571 0.9×	444 0.8×	319 0.8×	130 0.4×	31	2.2k
Marcelo G. Roma Argentina	27	673 0.8×	1.2k 2.0×	808 1.5×	626 1.5×	580 1.6×	92	2.7k
Raffaella Maria Gadaleta Italy	22	1.0k 1.2×	980 1.6×	660 1.2×	727 1.8×	131 0.4×	41	2.4k
Xiaojiaoyang Li China	33	1.6k 1.9×	525 0.9×	1.1k 1.9×	442 1.1×	662 1.9×	98	3.4k
Fengjie Huang China	29	1.3k 1.5×	502 0.8×	611 1.1×	354 0.9×	174 0.5×	54	2.5k
Caroline Aninat France	19	855 1.0×	329 0.5×	325 0.6×	208 0.5×	620 1.7×	34	2.2k
María J. Perez Spain	21	414 0.5×	636 1.0×	388 0.7×	314 0.8×	213 0.6×	32	1.5k
Adriana Carino Italy	27	742 0.9×	1.0k 1.7×	619 1.1×	583 1.4×	149 0.4×	59	2.1k

Countries citing papers authored by Jocelyn Trottier

Since Specialization

Citations

This map shows the geographic impact of Jocelyn Trottier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jocelyn Trottier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jocelyn Trottier more than expected).

Fields of papers citing papers by Jocelyn Trottier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jocelyn Trottier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jocelyn Trottier. The network helps show where Jocelyn Trottier may publish in the future.

Co-authorship network of co-authors of Jocelyn Trottier

This figure shows the co-authorship network connecting the top 25 collaborators of Jocelyn Trottier. A scholar is included among the top collaborators of Jocelyn Trottier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jocelyn Trottier. Jocelyn Trottier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

d’Oplinter, Alice de Wouters, Bruno Marcotte, Thibault Varin, et al.. (2024). Rebaudioside D decreases adiposity and hepatic lipid accumulation in a mouse model of obesity. Scientific Reports. 14(1). 3077–3077. 7 indexed citations

Mahdavi, Atena, Jocelyn Trottier, Olivier Barbier, Michel Lebel, & Iwona Rudkowska. (2023). Dairy Intake Modifies the Level of the Bile Acid Precursor and Its Correlation with Serum Proteins Associated with Cholesterol Clearance in Subjects with Hyperinsulinemia. Nutrients. 15(22). 4707–4707. 1 indexed citations

Daniel, Noëmie, Thibault Varin, Jocelyn Trottier, et al.. (2021). Dietary fat and low fiber in purified diets differently impact the gut-liver axis to promote obesity-linked metabolic impairments. American Journal of Physiology-Gastrointestinal and Liver Physiology. 320(6). G1014–G1033. 13 indexed citations

Anhê, Fernando F., Renato Tadeu Nachbar, Thibault Varin, et al.. (2018). Treatment with camu camu ( Myrciaria dubia ) prevents obesity by altering the gut microbiota and increasing energy expenditure in diet-induced obese mice. Gut. 68(3). 453–464. 231 indexed citations

Lü, Wenqi, Mei‐Fei Yueh, Robert H. Tukey, et al.. (2017). Crypt Organoid Culture as an In Vitro Model in Drug Metabolism and Cytotoxicity Studies. Drug Metabolism and Disposition. 45(7). 748–754. 39 indexed citations

Song, Yongfeng, Chune Liu, Jocelyn Trottier, et al.. (2017). H19 promotes cholestatic liver fibrosis by preventing ZEB1‐mediated inhibition of epithelial cell adhesion molecule. Hepatology. 66(4). 1183–1196. 126 indexed citations

Wunsch, Ewa, Marcin Krawczyk, Małgorzata Milkiewicz, et al.. (2016). Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases. Scientific Reports. 6(1). 30847–30847. 47 indexed citations

Wunsch, Ewa, Małgorzata Milkiewicz, Urszula Wasik, et al.. (2015). Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease. Scientific Reports. 5(1). 79 indexed citations

White, Phillip J., Patricia L. Mitchell, Michael Schwab, et al.. (2015). Transgenic ω-3 PUFA enrichment alters morphology and gene expression profile in adipose tissue of obese mice: Potential role for protectins. Metabolism. 64(6). 666–676. 37 indexed citations

10.

Wunsch, Ewa, Jocelyn Trottier, Małgorzata Milkiewicz, et al.. (2014). Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis. Hepatology. 60(3). 931–940. 93 indexed citations

11.

Perreault, Martin, Jocelyn Trottier, Mélanie Verreault, et al.. (2013). The Human UDP-Glucuronosyltransferase UGT2A1 and UGT2A2 Enzymes Are Highly Active in Bile Acid Glucuronidation. Drug Metabolism and Disposition. 41(9). 1616–1620. 34 indexed citations

12.

Perreault, Martin, Andrzej Białek, Jocelyn Trottier, et al.. (2013). Role of Glucuronidation for Hepatic Detoxification and Urinary Elimination of Toxic Bile Acids during Biliary Obstruction. PLoS ONE. 8(11). e80994–e80994. 40 indexed citations

13.

Trottier, Jocelyn, Andrzej Białek, Patrick Caron, et al.. (2011). Profiling Circulating and Urinary Bile Acids in Patients with Biliary Obstruction before and after Biliary Stenting. PLoS ONE. 6(7). e22094–e22094. 91 indexed citations

14.

Verreault, Mélanie, Jenny Kaeding, Patrick Caron, et al.. (2009). Regulation of endobiotics glucuronidation by ligand-activated transcription factors: physiological function and therapeutic potential. Drug Metabolism Reviews. 42(1). 110–122. 21 indexed citations

15.

Barbier, Olivier, Jocelyn Trottier, Jenny Kaeding, Patrick Caron, & Mélanie Verreault. (2009). Lipid-activated transcription factors control bile acid glucuronidation. Molecular and Cellular Biochemistry. 326(1-2). 3–8. 65 indexed citations

16.

Trottier, Jocelyn, Diala El Husseini, Martin Perreault, et al.. (2009). The Human UGT1A3 Enzyme Conjugates Norursodeoxycholic Acid into a C23-ester Glucuronide in the Liver. Journal of Biological Chemistry. 285(2). 1113–1121. 18 indexed citations

17.

Verreault, Mélanie, Jocelyn Trottier, Jessica A. Bonzo, et al.. (2006). The liver X-receptor alpha controls hepatic expression of the human bile acid–glucuronidating UGT1A3 enzyme in human cells and transgenic mice. Hepatology. 44(2). 368–378. 54 indexed citations

18.

Chen, Shujuan, Jessica A. Bonzo, Upendra A. Argikar, et al.. (2006). Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation. Drug Metabolism and Disposition. 35(3). 419–427. 87 indexed citations

19.

Trottier, Jocelyn, Mélanie Verreault, Susan Grepper, et al.. (2006). Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver. Hepatology. 44(5). 1158–1170. 103 indexed citations

20.

Chen, Shujuan, Nghia Nguyen, Upendra A. Argikar, et al.. (2005). Tissue-specific, Inducible, and Hormonal Control of the Human UDP-Glucuronosyltransferase-1 (UGT1) Locus. Journal of Biological Chemistry. 280(45). 37547–37557. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact